TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"
Sponsored by Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
About this trial
Last updated a year ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Ended a year ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* ≥18 years old
* Admitted for STEMI or NSTEMI and invasive management (i.e. coronary angiography during index hospitalization).
* LVEF>40% as evaluated by any imaging technique anytime during hospitalization.
* Signed informed consent
Exclusion Criteria
* Known allergy or intolerance to beta-blockers
* Absolute contraindication to beta-blocker therapy according to treating physician judge
* Prior history of HF, Killip class on admission or during hospitalization ≥ II
* Severe valvular heart disease (> 3+ for aortic or mitral insufficiency, aortic or mitral valve area ≤1.0 cm2).
* Any condition (appart from AMI) that requires beta-blocker prescription on discharge according to treating physician judge
* Any medical condition that, in the investigator´s judgment, would seriously limit life expectancy (less than one year),
* Patients participating in other clinical trials